MedGenome keeps $40 million for acquisitions this FY

Premium

MedGenome Inc., which is backed by Sequoia Capital, Novo Holdings and LeapFrog Investments among investors, has earmarked $40 million (around ₹329 crore) for acquisitions this financial year through March. In an interview, Mahesh Pratapneni, chief executive and co-founder, said the genomics research startup is targeting to close three deals in the ......